Bachem Aktie
WKN: 914589 / ISIN: CH0012530207
|
03.02.2026 14:20:14
|
A Quick Guide to Biotinylated Peptides
Biotinylated peptides have become important tools in modern biochemistry and drug discovery. By pairing the precision of synthetic peptides with biotin’s exceptionally strong binding properties to avidin and streptavidin, researchers gain powerful reagents for detection, purification, and interaction studies.Whether you’re developing immunoassays, mapping protein interactions, or screening drug candidates, knowing how to design and use biotinylated peptides effectively can make a major difference in the quality of your results.This guide walks through the essentials: how biotinylated peptides are made, where they’re used, and how to troubleshoot common issues.What are biotinylated peptides?Biotin (vitamin H or B7) is best known for its extremely high affinity for streptavidin and avidin, forming one of the strongest non-covalent interactions known, with dissociation constants around 10⁻¹⁵ M. Because this binding is so tight and reliable, biotin makes an excellent molecular tag.Peptide biotinylationPeptide biotinylation involves covalently attaching biotin to a synthetic peptide. Common attachment sites include: N-terminus C-terminusLysine side chainsBiotin needs proper positioning to bind to avidin or streptavidin well. Close proximity to the peptide surface could lead to steric hindrance. To avoid this, chemists often add spacer molecules, such as PEG linkers, which increase flexibility and improve accessibility.Simple biotinylated peptide structureBiotinLinker (e.g. PEG)Peptide SequenceBinds avidin/streptavidinProvides spatialTarget recognition domainBiotinylated peptides vs. proteinsWhen comparing biotinylated peptides vs proteins, peptides offer:Precise control over where biotin is attachedDefined stoichiometryHomogeneous productsIn contrast, proteins usually involve multiple lysines and produce mixed biotinylated populations. Peptides can give you cleaner, more consistent results. Synthesis and design basicsOne of the most common ways biotinylated peptides are being produced is by using using solid-phase peptide synthesis (SPPS) with Fmoc chemistry. Biotin can be added:During SPPS, using Fmoc-biotin building blocksAfter synthesis through solution-phase conjugationUse pre-biotinylated resins, which attach biotin at the C-terminus tKey design parametersThree important design parameters determine the performance of biotinylated peptides:Attachment siteN- or C-terminal biotin is preferred when the internal sequence must stay unmodified for activityInternal biotinylation is useful when the termini are important, but the chosen site must not disrupt binding or structureSpacer lengthTypical optimal length: 6-12 atomsShort spacers can lead to steric hinderanceLonger spacers increase accessibility but also costHydrophilic spacers (e.g., aminohexanoic acid, PEG) add flexibility and hydrophilicityPurity requirementsMost applications require >95% purity. This reduces background signals and off-target effects, especially in assays and cell-based experiments. Techniques such as HPLC and mass spectrometry verify the purity, sequences and successful biotin incorporation.Custom vs catalog peptidesWhen deciding between custom peptide synthesis and catalog peptide products, you need to consider several factors: ConsiderationCustom synthesisCatalog peptidesSequence specificityFully customizable Limited to available optionsScale Any amount Fixed sizesLead timeVariableShips immediatelyCostHigher for complex designsLowerQuality controlTailored QC and documentationStandard QCKey applications of biotinylated peptidesBiotinylated peptides combine specific peptide-target interactions with the robust biotin-streptavidin system. This makes them highly versatile in research and development.Application area Primary useKey advantageImmunoassaysDetection and quantificationStrong signal amplificationAffinity studiesProtein pull-downs, purificationHighly specific and reversible captureProteomicsProtein enrichment and identificationImproved detection and universal compatibilityDrug discoveryEpitope mapping and screeningHigh-throughput compatible, precise targetingCell biologyProximity labelling and trackingSpatial and temporal protein mappingBiosensorsSurface immobilizationOriented attachmentLet’s look at some common applications more closely.ImmunoassaysIn enzyme-linked immunosorbent assays (ELISAs), Western blots, and dot blots, biotinylated peptides serve as capture reagents or detection probes. When paired with enzyme-linked streptavidin (HRP, AP), they enable strong signal amplification and improved assay sensitivity.Typical uses include:Plate coating for antibody captureDetection probes in sandwich-format assaysEpitope-specific antibody characterizationDiagnostic assay development and optimizationAffinity and enrichmentBiotinylated peptides are widely used for selective protein isolation.Pull-downs – streptavidin beads capture biotinylated peptide-bound proteins for MS or Western blot Peptide microarrays – enable high-throughput interaction mappingProximity labeling controls (TurboID, APEX) – used as standards to validate labeling efficiencyDrug discoveryCommon rules include:Epitope mapping with overlapping peptide librariesHigh-throughput screening for inhibitors of protein-protein interactionsSAR studies with consistent and controlled biotinylationEmerging applications of biotinylated peptidesSuper-resolution microscopy – for precise localization studiesTargeted drug delivery – via biotin receptorsCell-surface engineering – to modify cellular properties for research and therapeutic useTroubleshooting and optimizationEven well-designed biotinylated peptides may require fine-tuning.Common issues and solutions include:Weak or absent signalIncrease spacer lengthVerify biotin incorporationAdjust peptide concentration or incubation timeTry alternative attachment sitesCheck qualityHigh background or non-specific bindingReduce biotin densityInclude biotin/streptavidin blocking stepsIncrease washing stringencyUse blocking agents (BSA, milk, commercial blockers)Address hydrophobic peptide aggregationPoor elution or recoveryBoil samples in SDS bufferUse competitive elution (limited effectiveness)Analyze proteins directly on beadsConsider desthiobiotin for reversible capturePeptide degradation or instabilityUse protease inhibitorsStore at –20°C or –80°C in aliquotsAvoid extreme pHConsider D-amino acids or stabilizing modificationsDesign optimization checklistAvoid modifying functionally essential residuesTest multiple sites if attachment location is unclearInclude controls (scrambled, non-biotinylated, streptavidin-only)Validate biotin activity before key experimentsNote storage conditions and lot numbersBachem: Your partner for biotinylated peptidesSuccessful biotinylated peptide experiments depend on both thoughtful design and high-quality materials.Bachem combines decades of peptide synthesis expertise with advanced analytical capabilities to produce biotinylated peptides that meet the stringent needs of modern research and drug development.We provide: Flexible biotinylation options Production at any scale Rigorous quality control and full documentationSupport for GMP and regulatory workflowsWhether you’re developing diagnostic assays, running drug discovery and development campaigns, or advancing proteomics, Bachem’s experts can support you throughout your project to ensure the best possible outcomes.Contact us to learn how our expertise in peptide chemistry can accelerate your research and development programs.Subscribe to our general newsletter/* "function"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn("The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1."),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener("gform_main_scripts_loaded",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener("gform/theme/scripts_loaded",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener("DOMContentLoaded",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook("action",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook("filter",o,r,e,t)},doAction:function(o){gform.doHook("action",o,arguments)},applyFilters:function(o){return gform.doHook("filter",o,arguments)},removeAction:function(o,r){gform.removeHook("action",o,r)},removeFilter:function(o,r,e){gform.removeHook("filter",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+"_"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){"function"!=typeof(t=o.callable)&&(t=window[t]),"action"==r?t.apply(null,e):e[0]=t.apply(null,e)})),"filter"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});/* ]]> */ "*" indicates required fields Δ/* Name* First Last Email Address*Country AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Consent*Privacy Policy I have read, understood and agree to the Privacy Policy.This field is hidden when viewing the formSubmission Time Hours : Minutes /* = 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_1');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_1').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_1').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_1').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_1').removeClass('gform_validation_error');}setTimeout( function() { /* delay the scroll by 50 milliseconds to fix a bug in chrome */ }, 50 );if(window['gformInitDatepicker']) {gformInitDatepicker();}if(window['gformInitPriceFields']) {gformInitPriceFields();}var current_page = jQuery('#gform_source_page_number_1').val();gformInitSpinner( 1, 'https://www.bachem.com/wp-content/plugins/gravityforms/images/spinner.svg', true );jQuery(document).trigger('gform_page_loaded', [1, current_page]);window['gf_submitting_1'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_1').replaceWith(confirmation_content);jQuery(document).trigger('gform_confirmation_loaded', [1]);window['gf_submitting_1'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_1').text());}else{jQuery('#gform_1').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger("gform_pre_post_render", [{ formId: "1", currentPage: "current_page", abort: function() { this.preventDefault(); } }]); if (event && event.defaultPrevented) { return; } const gformWrapperDiv = document.getElementById( "gform_wrapper_1" ); if ( gformWrapperDiv ) { const visibilitySpan = document.createElement( "span" ); visibilitySpan.id = "gform_visibility_test_1"; gformWrapperDiv.insertAdjacentElement( "afterend", visibilitySpan ); } const visibilityTestDiv = document.getElementById( "gform_visibility_test_1" ); let postRenderFired = false; function triggerPostRender() { if ( postRenderFired ) { return; } postRenderFired = true; gform.core.triggerPostRenderEvents( 1, current_page ); if ( visibilityTestDiv ) { visibilityTestDiv.parentNode.removeChild( visibilityTestDiv ); } } function debounce( func, wait, immediate ) { var timeout; return function() { var context = this, args = arguments; var later = function() { timeout = null; if ( !immediate ) func.apply( context, args ); }; var callNow = immediate && !timeout; clearTimeout( timeout ); timeout = setTimeout( later, wait ); if ( callNow ) func.apply( context, args ); }; } const debouncedTriggerPostRender = debounce( function() { triggerPostRender(); }, 200 ); if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) { const observer = new MutationObserver( ( mutations ) => { mutations.forEach( ( mutation ) => { if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) { debouncedTriggerPostRender(); observer.disconnect(); } }); }); observer.observe( document.body, { attributes: true, childList: false, subtree: true, attributeFilter: [ 'style', 'class' ], }); } else { triggerPostRender(); } } );} ); /* ]]> */The post A Quick Guide to Biotinylated Peptides appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bachem AG
| Keine Nachrichten verfügbar. |